J Korean Med Sci.  2016 Oct;31(10):1553-1559. 10.3346/jkms.2016.31.10.1553.

A Survey of Antimicrobial Stewardship Programs in Korea, 2015

• Kim B
• Kim J
• Kim SW
• Pai H

• KMID: 2468244
• DOI: http://doi.org/10.3346/jkms.2016.31.10.1553

Abstract

The study was conducted to evaluate the Antibiotic Stewardship Program (ASP) in Korean hospitals compared with the previous two surveys in 2006 and 2012. The information on ASPs was collected through an online-based survey sent by e-mail to 192 infectious diseases specialists in 101 Korean hospitals in September 2015. Fifty-four hospitals (53.5%, 54/101) responded to the online survey. One infectious diseases specialist was employed in 30 (55.6%) of the 54 hospitals, and they were in charge of ASPs in hospitals with the program. Fifty of the 54 hospitals (92.6%) had ASPs and the same number of hospitals was conducting a preauthorization-of-antibiotics-use program. Although most hospitals adopted preauthorization strategies for more antibiotics in 2015 than in 2012 (median 14 in 2015; 13 in 2012), a limited number of antibiotics were under control. The number of per oral and parenteral antibiotics available in hospitals in 2015 decreased compared to 2006 and 2012. The number of hospitals performing a retrospective or prospective qualitative drug use evaluation of antibiotic use increased from 2006 to 2015. Manpower in charge of antibiotic stewardship in most hospitals was still very limited and ASPs heavily depended on preauthorization-of-antibiotics-use programs in this survey. In conclusion, there leaves much to be desired in ASPs in Korea in 2015.

Keyword

Stewardship; Antimicrobial; Antibiotic; Korea; 2015

MeSH Terms

Anti-Bacterial Agents/therapeutic use
Anti-Infective Agents/therapeutic use
Communicable Diseases/drug therapy
Drug Monitoring
Drug Prescriptions/*statistics & numerical data
Electronic Mail
Hospitals
Humans
Pharmacy and Therapeutics Committee/*organization & administration
Physicians/psychology
Republic of Korea
Surveys and Questionnaires
Anti-Bacterial Agents
Anti-Infective Agents

Figure

• 

  Fig. 1 The change of hospital proportions according to preauthorization-required antibiotics: a comparison of the 2006 (n = 43), 2012 (n = 40) and 2015 (n = 50) surveys.

Reference

1. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J Jr; Infectious Diseases Society of America. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46:155–164.

2. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48:1–12.

3. Giske CG, Monnet DL, Cars O, Carmeli Y. ReAct-Action on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008; 52:813–821.

4. Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009; 49:1175–1184.

5. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005; 18:638–656.

6. Bang JH, Song KH, Park WB, Kim SH, Cho JH, Kim HB, Kim NJ, Oh M, Choe KW. A survey on antimicrobial prescriptions and stewardship programs in Korea. Infect Chemother. 2006; 38:316–324.

7. Kim HI, Kim SW, Chang HH, Kim HB. A survey of antimicrobial stewardship programs in Korean hospitals. Korean J Med. 2014; 87:173–181.

8. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44:159–177.

9. Kim JY, Jo YM, Choi WS, Yoon YK, Jeong HW, Park DW, Sohn JW, Kim YM, Kim MJ. Usefulness of computerized restricted antibiotics use and control program in a tertiary care hospital. Infect Chemother. 2006; 38:235–241.

10. Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF Jr, Lloyd JF, Burke JP. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med. 1998; 338:232–238.

11. Wilf-Miron R, Ron N, Ishai S, Chory H, Abboud L, Peled R. Reducing the volume of antibiotic prescriptions: a peer group intervention among physicians serving a community with special ethnic characteristics. J Manag Care Pharm. 2012; 18:324–328.

12. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, Ramsay CR, Wiffen PJ, Wilcox M. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013; CD003543.

13. Song YJ, Kim M, Huh S, Lee J, Lee E, Song KH, Kim ES, Kim HB. Impact of an antimicrobial stewardship program on unnecessary double anaerobic coverage prescription. Infect Chemother. 2015; 47:111–116.

14. Goff DA, Bauer KA, Reed EE, Stevenson KB, Taylor JJ, West JE. Is the “low-hanging fruit” worth picking for antimicrobial stewardship programs? Clin Infect Dis. 2012; 55:587–592.

15. Stevenson KB, Balada-Llasat JM, Bauer K, Deutscher M, Goff D, Lustberg M, Pancholi P, Reed E, Smeenk D, Taylor J, et al. The economics of antimicrobial stewardship: the current state of the art and applying the business case model. Infect Control Hosp Epidemiol. 2012; 33:389–397.

16. Johannsson B, Beekmann SE, Srinivasan A, Hersh AL, Laxminarayan R, Polgreen PM. Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol. 2011; 32:367–374.

17. Oh JT, Kim SW, Son JW, Do BH, Han SW, Shin BC, Park JH, Lee JM, Kim NS. The effect of aminoglycoside restriction on the resistance pattern and mortality of nosocomial bacteremia caused by gram-negative bacilli. Infect Chemother. 2003; 35:192–198.

18. Aubert G, Carricajo A, Vautrin AC, Guyomarc’h S, Fonsale N, Page D, Brunel P, Rusch P, Zéni F. Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit. J Hosp Infect. 2005; 59:83–89.

19. Allegranzi B, Luzzati R, Luzzani A, Girardini F, Antozzi L, Raiteri R, Di Perri G, Concia E. Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. J Hosp Infect. 2002; 52:136–140.

20. Yoon YK, Park GC, An H, Chun BC, Sohn JW, Kim MJ. Trends of antibiotic consumption in Korea according to national reimbursement data (2008-2012): a population-based epidemiologic study. Medicine (Baltimore). 2015; 94:e2100.